Skip to main content
David Cohen, MD, Cardiology, Roslyn, NY

DavidJCohenMD

Cardiology Roslyn, NY

Adult Congenital Heart Disease, Interventional Cardiology

Professor, Internal Medicine, University of Missouri, Kansas City School of Medicine

Dr. Cohen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Cohen's full profile

Already have an account?

  • Office

    100 Port Washington Blvd
    Ste 105
    Roslyn, NY 11576
    Phone+1 516-390-9640
    Fax+1 816-756-3645

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1989 - 1994
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
  • Harvard Medical School
    Harvard Medical SchoolClass of 1986

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1989 - 2025
  • MO State Medical License
    MO State Medical License 2006 - 2025
  • NY State Medical License
    NY State Medical License 2020 - 2025
  • KS State Medical License
    KS State Medical License 2006 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Journal Articles

  • Coronary Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights from the OPEN-CTO Re...  
    David J Cohen, Sophia Airhart, J Aaron Grantham, Adam C Salisbury, James M McCabe, John A Spertus, ScienceDirect
  • Original Investigation Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial  
    Eugene H Blackstone, Vinod H Thourani, Howard C Herrmann, David J Cohen, Martin B Leon, Michael J Mack, Raj R Makkar, Samir R Kapadia, Susheel K Kodali, Lars G Svensso..., ScienceDirect
  • Original Investigations Long-Term Survival Following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-on Study)  
    Michael Domanski, Samin K Sharma, David J Cohen, Valentin Fuster, George D Dangas, ScienceDirect
  • Join now to see all

Authored Content

  • Less Is Still More in Patients with Acute Myocardial Infarction and Cardiogenic ShockAugust 2018
  • Reply Cost-Effectiveness of Long-Term Ticagrelor in Patients with Prior Myocardial Infarction: Analysis by SubgroupsJanuary 2018

Press Mentions

  • OPTION: LAAO Matches up to DOACs After Ablation, but Questions Remain
    OPTION: LAAO Matches up to DOACs After Ablation, but Questions RemainNovember 18th, 2024
  • ALIGN-AR at 2 Years Shows Promise for TAVI with Trilogy in Aortic Regurgitation
    ALIGN-AR at 2 Years Shows Promise for TAVI with Trilogy in Aortic RegurgitationOctober 29th, 2024
  • After DanGer Shock’s Win in AMICS for Impella: What’s Next?
    After DanGer Shock’s Win in AMICS for Impella: What’s Next?April 7th, 2024